Search results
Genentech's legacy and future aspirations are built on the belief that the boundaries of science are meant to be broken and that we can solve some of the hardest biomedical challenges plaguing humankind.
- Careers Login
The little things we do every day add up to big...
- Genentech: Our Medicines
You may also report side effects to Genentech at (888)...
- Genentech: Contact Us
Phone: 1 (877) GENENTECH (436-3683) Hours: Monday - Friday,...
- Our Pipeline
Pipeline. Rigorous and groundbreaking science has always...
- Visit Us
All of Genentech's U.S. sites are united by our goal of...
- Genentech: About Us
Considered the founder of the industry, Genentech, now a...
- Call Us
Genentech Patient Foundation. The Genentech Patient...
- Medical Professionals
Genentech Access Solutions offers your patients coverage...
- Careers Login
Genentech is a biotechnology company that discovers and develops medicines for serious and life-threatening diseases. Learn about its history, mission, values, and podcast series on human biology.
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. Historically, the company is regarded as the world's first biotechnology company.
Find prescribing information, medication guides, healthcare provider letters, and safety data sheets for Genentech's biologic products. Browse by product name, indication, or therapeutic area.
Genentech is a biotechnology company that creates and delivers innovative medicines for various conditions. Learn about its history, specialties, locations, employees, updates, and community involvement on LinkedIn.
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
In its commitment to diversity and inclusion, Genentech has set the goal of establishing itself as a leader and partner of choice in advancing health equity by 2025. Read the Great Place To Work...